Stanford Cancer Team Halts Growth of Multiple Myeloma and Diffuse Large B Cell Lymphoma in Mice with Custom Molecule sBCMA-Fc V3

Compared with a control (left), treatment with a soluble BCMA decoy receptor (right) increases the number of dying cancer cells (brown) in a multiple myeloma tumor growing in mice.

« Stanford Cancer Team Halts Growth of Multiple Myeloma and Diffuse Large B Cell Lymphoma in Mice with Custom Molecule sBCMA-Fc V3

Expert Pitch

Expert Query

Expert Directory